Topiramate oral solution changes from Part VIIIB to Part VIIIA in March 2019 Drug Tariff

Topiramate oral solution changes from Part VIIIB to Part VIIIA in March 2019 Drug Tariff

March 6, 2019

The following unlicensed (special) products have been deleted from Part VIIIB of the Drug Tariff from 1st March 2019,

Topiramate 100mg/5ml oral suspension
Topiramate 50mg/5ml oral suspension

Licensed alternatives for these products (listed below) are now available and can be found in Part VIIIA of Drug Tariff as of 1st March 2019.

Topiramate 100mg/5ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd)
Topiramate 50mg/5ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd)

Any changes to Part VIII of the Drug Tariff impacts reimbursement so it is important to take note when amendments are made to product listings.

 



Posted in:


More Latest News >